We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest Industry Insights
Going Label-Free: The Future of Metabolomics Imaging
Industry Insight

Going Label-Free: The Future of Metabolomics Imaging

The study of brain tumors using real-time imaging of the brain in live disease models is critical for elucidating disease mechanisms and developing novel treatment strategies. Such research requires full characterization of healthy and disease phenotypes using a multi-omics analysis, as described in this blog.
Will the Potential of Proteomics Be Realized in 2020?
Industry Insight

Will the Potential of Proteomics Be Realized in 2020?

Technology Networks recently spoke with Stephen Williams, CMO at biotechnology company SomaLogic, to learn more about research progress in the proteomics space and the technology that has enabled it.
 Efforts To Sequence the Coronavirus Continue As New Gene Sequencer Is Launched in Asia
Industry Insight

Efforts To Sequence the Coronavirus Continue As New Gene Sequencer Is Launched in Asia

Technology Networks spoke with GenapSys to learn more about the sequencer which is "100x smaller and less expensive than legacy high-throughput sequencers" and how it can be applied to study the Coronavirus.
Data from Direct-to-Consumer Genetic Tests Used To Create a Drug for Inflammatory Diseases
Industry Insight

Data from Direct-to-Consumer Genetic Tests Used To Create a Drug for Inflammatory Diseases

At the beginning of the year, direct-to-consumer (DTC) genetic testing company 23andMe announced that they have generated a bispecific antibody that blocks the IL-36 cytokine family associated with multiple inflammatory diseases. Technology Networks spoke with Christine Pai from 23andMe to find out more.
Facilitating Cell Culture Growth and Protecting Protein Integrity
Industry Insight

Facilitating Cell Culture Growth and Protecting Protein Integrity

Many biotherapeutic drugs such as recombinant antibodies are manufactured utilizing host cells, a common example being Chinese hamster ovary (CHO) cells. A key factor for consideration in this process is the growth and viability of these cells – ultimately this influences the quality and quantity of the biotherapeutic product. Technology Networks spoke with Nicole Wellens, Global Product Manager for BioTherapeutics Media, Lonza to learn more about the new feed and how it has been developed.
Reducing Errors in Whole Genome Sequencing: It Starts With Library Prep
Industry Insight

Reducing Errors in Whole Genome Sequencing: It Starts With Library Prep

The highly complex process of whole genome sequencing comes with a high cost of error. One pipetting or mixing mistake can lead to costly errors downstream. When working with multiple samples, error-free sample handling and proper mixing becomes even more critical. The first step in the process to prepare the sample for sequencing, library prep, is a vital step that, if not done correctly, can lead to flawed data and costly delays.
Using Protein Biomarkers Increases the Chances of Success in Clinical Trials
Industry Insight

Using Protein Biomarkers Increases the Chances of Success in Clinical Trials

Many clinical trials fail due to lack of efficacy. But while some of this may be due to poor target selection during the drug discovery process, it’s becoming increasingly clear that only certain patients respond to treatments. So how exactly does precision medicine increase the likelihood of success in clinical trials?
An Online Educational Resource for Cell Scientists
Industry Insight

An Online Educational Resource for Cell Scientists

Introduced back in March 2019, Cell MentorTM is an online educational resource for biology students and researchers, created by Cell Signaling Technology and Cell Press. To open the resource up to even more scientists, a Chinese version of the site was recently launched.
Detecting Sepsis Early
Industry Insight

Detecting Sepsis Early

We recently spoke to Elena Sukhacheva, Director Medical and Scientific Affairs at Beckman Coulter, to learn about some of the challenges of diagnosing sepsis early, and how measuring Monocyte Distribution Width can be used as a sepsis biomarker to aid the process.
Looking Back on Gene Editing Advances in 2019 and Towards What the Future May Hold
Industry Insight

Looking Back on Gene Editing Advances in 2019 and Towards What the Future May Hold

With constant conversations examining the potential of CRISPR technology, it can be hard to focus on what has been achieved since 2012 and to look toward the future to determine what may be achievable both in the near – and longer – term.
Advertisement